Show Menu

A fully integrated developer and manufacturer of ovine polyclonal therapeutics, targeting infectious disease and acute toxic events

News: Archive for December 2014

Ovine antibodies to treat Ebola

MicroPharm Limited is pleased to announce that it is developing ovine polyclonal antibodies against Ebola  in collaboration with Public Health England (PHE) and the University of Oxford, and our candidate is one of twenty going through the first round of evaluation by PHE for efficacy against the  Ebola virus.

Read the full story

Posted on: Friday, 19th December 2014